Global Behcet’s Disease Market By Symptoms (Recurring Mouth Sores/ genital sores, Skin and joint pain, Inflammation in the eyes, Vein Inflammation, Bowel Problems, Others); By Diagnosis (Blood Test, Pathergy Test); By Treatment (Skin creams, gels and ointments, Eyedrops, Corticosteroids, Immunosuppressant drugs, Others); By Age Group (Children, Adults, Geriatric); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global behcet’s disease market is growing at an estimated CAGR of 8% over the forecast period. Behcet's disease more commonly known as Behcet's syndrome, happens to be a rare disorder in which the human body sees inflammation of blood vessels. Symptoms of this rare disease are not at all related and are inclusive of mouth sores, eye inflammation, genital sores, and skin rashes along with lesions. The treatment of this syndrome is inclusive of certain medications that helping in bringing down the signs and symptoms, and in preventing severe complications like loss of eyesight. Behcet's disease symptoms are likely to differ from individual to individual, and can fluctuate over time. Signs and symptoms are completely dependent on those parts of the body are affected. Behcet's disease has been said to be an autoimmune disorder that means the immune system of the body attacks some of its own healthy cells by mistake. According to medical experts, the symptoms for this disease are likely to dependant on genetic and environmental factors. These symptoms are considered to be because of inflammation of the blood vessels known as vasculitis. Several factors are helping in the growth of the global Behcet’s disease market.
The growth of the global behcet’s disease market didn’t see much deviations in terms of revenue generation during the coronavirus pandemic. The chances of occurrence of COVID-19 in patients suffering this syndrome was not higher.
Symptoms Outlook
On the basis of symptoms, the global behcet’s disease market has been divided into recurring mouth sores/ genital sores, skin and joint pain, inflammation in the eyes, vein inflammation, bowel problems and others. Recurring mouth sores look extremely look similar to canker sores happen to be most common sign of this syndrome. These sores start as raised, round lesions in the mouth which very rapidly turn into ulcers that are painful. As these sores normally heal within one to three weeks, they do reoccur. Meanwhile few people develop sores that are just like on their skin, others witness development of red, raised and tender nodules located on their skin, specifically on the lower legs.
Global Behcet’s Disease Market Revenue & Forecast, (US$ Million), 2022 – 2030
Diagnosis Outlook
On the basis of diagnosis, the global behcet’s disease market has been categorised into blood test and pathergy test. Compared to blood tests, pathergy tests are preferred more by medical experts in determining whether one has this syndrome or not. The pathergy test happens to be a nonspecific hypersensitivity skin reaction which is induced through needle prick. This needle prick is performed to check any evidence of this phenomenon.
Treatment Outlook
The treatment segment of the global behcet’s disease market has been divided into skin creams, gels and ointment, eyedrops, corticosteroids, immunosuppressant drugs and others. The immunosuppressant drugs segment accounts for majority of revenue generated by this market. The inflammation that is linked with Behcet's disease can be brought down by drugs that prevent one’s immune system from launching an attack on those tissues that are healthy. These drugs are likely to include azathioprine, cyclosporine along with cyclophosphamide.
Age Group Outlook
The age group of the global behcet’s disease market has been divided into children, adults and geriatric. The adults segment dominates in terms of market share for this market. Nearly 55 percent of patients are adults, followed by kids who account for nearly 36 percent of patients.
Region Outlook
On the basis of region, the global behcet’s disease market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America has been dominating in terms of generating most of the revenue for this market. Every year, nearly 15,000 – 20,000 people suffer from Behcet's disease and prevalence of this syndrome in the United States is 0.12-0.33 case per 1 lakh people.
Competitive Landscape
The report provides both, qualitative and quantitative research of global behcet’s disease market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
A few of the key players operating in the global behcet’s disease market are listed below:
- Amgen Inc
- Aristea Therapeutics
- CELGENE CORPORATION (a BRISTOL-MYERS SQUIBB COMPANY)
- Eisai Co. Ltd
- KANGPU
- XOMA Corporation
- Other Market Participants
Global Behcet’s Disease Market
By Symptoms
- Recurring Mouth sores/ genital sores
- Skin and joint pain
- Inflammation in the eyes
- Vein Inflammation
- Bowel Problems
- Others
By Diagnosis
- Blood Test
- Pathergy test
By Treatment
- Skin creams, gels and ointments
- Eyedrops
- Corticosteroids
- Immunosuppressant drugs
- Others
By Age Group
- Children
- Adults
- Geriatric
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1.
Market
Segmentation
1.2.
Years
Considered
1.2.1.
Historic
Years: 2015 - 2020
1.2.2.
Base
Year: 2021
1.2.3.
Forecast
Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1.
Primary
Research
3.1.1.
Research
Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2.
Secondary
Research
3.2.1.
Paid
Databases
3.2.2.
Secondary
Sources
3.3.
Market
Size Estimates
3.3.1.
Top-Down
Approach
3.3.2.
Bottom-Up
Approach
3.4.
Data
Triangulation Methodology
3.5.
Research
Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Behcet’s Disease Market
6.
Market
Synopsis: Behcet’s Disease Market
7.
Behcet’s
Disease Market Analysis: Qualitative Perspective
7.1.
Introduction
7.1.1.
Product
Definition
7.1.2.
Industry
Development
7.2.
Market
Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3.
Trends
in Behcet’s Disease Market
7.4.
Market
Determinants Radar Chart
7.5.
Macro-Economic
and Micro-Economic Indicators: Behcet’s Disease Market
7.6.
Porter’s
Five Force Analysis
7.7.
Impact
of Covid-19 on Behcet’s Disease Market
8.
Global Behcet’s
Disease Market Analysis and Forecasts, 2022 - 2030
8.1.
Overview
8.1.1.
Global Behcet’s
Disease Market Revenue (US$ Mn)
8.2.
Global Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
8.2.1.
Recurring
Mouth sores/ genital sores
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2.
Skin and
joint pain
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.2.3.
Inflammation
in the eyes
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 - 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 - 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 - 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 - 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 - 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 - 2030
8.2.4.
Vein
Inflammation
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.4.3.
Market
Forecast, 2022 - 2030
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2021
8.2.4.5.1.2. Market Forecast, 2022 - 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2021
8.2.4.5.2.2. Market Forecast, 2022 - 2030
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2021
8.2.4.5.3.2. Market Forecast, 2022 - 2030
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2021
8.2.4.5.4.2. Market Forecast, 2022 - 2030
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2021
8.2.4.5.5.2. Market Forecast, 2022 - 2030
8.2.5.
Bowel
Problems
8.2.5.1.
Definition
8.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.5.3.
Market
Forecast, 2022 - 2030
8.2.5.4.
Compound
Annual Growth Rate (CAGR)
8.2.5.5.
Regional
Bifurcation
8.2.5.5.1.
North
America
8.2.5.5.1.1. Market Estimation, 2015 - 2021
8.2.5.5.1.2. Market Forecast, 2022 - 2030
8.2.5.5.2.
Europe
8.2.5.5.2.1. Market Estimation, 2015 - 2021
8.2.5.5.2.2. Market Forecast, 2022 - 2030
8.2.5.5.3.
Asia
Pacific
8.2.5.5.3.1. Market Estimation, 2015 - 2021
8.2.5.5.3.2. Market Forecast, 2022 - 2030
8.2.5.5.4.
Middle
East and Africa
8.2.5.5.4.1. Market Estimation, 2015 - 2021
8.2.5.5.4.2. Market Forecast, 2022 - 2030
8.2.5.5.5.
Latin
America
8.2.5.5.5.1. Market Estimation, 2015 - 2021
8.2.5.5.5.2. Market Forecast, 2022 - 2030
8.2.6.
Others
8.2.6.1.
Definition
8.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.6.3.
Market
Forecast, 2022 - 2030
8.2.6.4.
Compound
Annual Growth Rate (CAGR)
8.2.6.5.
Regional
Bifurcation
8.2.6.5.1.
North
America
8.2.6.5.1.1. Market Estimation, 2015 - 2021
8.2.6.5.1.2. Market Forecast, 2022 - 2030
8.2.6.5.2.
Europe
8.2.6.5.2.1. Market Estimation, 2015 - 2021
8.2.6.5.2.2. Market Forecast, 2022 - 2030
8.2.6.5.3.
Asia Pacific
8.2.6.5.3.1. Market Estimation, 2015 - 2021
8.2.6.5.3.2. Market Forecast, 2022 - 2030
8.2.6.5.4.
Middle
East and Africa
8.2.6.5.4.1. Market Estimation, 2015 - 2021
8.2.6.5.4.2. Market Forecast, 2022 - 2030
8.2.6.5.5.
Latin
America
8.2.6.5.5.1. Market Estimation, 2015 - 2021
8.2.6.5.5.2. Market Forecast, 2022 - 2030
8.3.
Key
Segment for Channeling Investments
8.3.1.
By
Symptoms
9.
Global Behcet’s
Disease Market Analysis and Forecasts, 2022 - 2030
9.1.
Overview
9.2.
Global Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
9.2.1.
Blood
Test
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market Forecast,
2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2.
Pathergy
test
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.3.
Key
Segment for Channeling Investments
9.3.1.
By
Diagnosis
10. Global Behcet’s Disease Market Analysis and
Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Treatment
10.2.1. Skin creams, gels and ointments
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Eyedrops
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Corticosteroids
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Immunosuppressant drugs
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 - 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.2.5. Others
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 - 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 - 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 - 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 - 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 - 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Treatment
11. Global Behcet’s Disease Market Analysis and
Forecasts, 2022 - 2030
11.1. Overview
11.2. Global Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Age Group
11.2.1. Children
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 - 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 - 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 - 2030
11.2.2. Adults
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 - 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 - 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 - 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 - 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 - 2030
11.2.3. Geriatric
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 - 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 - 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 - 2030
11.3. Key Segment for Channeling Investments
11.3.1. By Age Group
12. North America Behcet’s Disease Market
Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. North America Behcet’s Disease Market Revenue
(US$ Mn)
12.2. North America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Symptoms
12.2.1. Recurring Mouth sores/ genital sores
12.2.2. Skin and joint pain
12.2.3. Inflammation in the eyes
12.2.4. Vein Inflammation
12.2.5. Bowel Problems
12.2.6. Others
12.3. North America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
12.3.1. Blood Test
12.3.2. Pathergy test
12.4. North America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Treatment
12.4.1. Skin creams, gels and ointments
12.4.2. Eyedrops
12.4.3. Corticosteroids
12.4.4. Immunosuppressant drugs
12.4.5. Others
12.5. North America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Age Group
12.5.1. Children
12.5.2. Adults
12.5.3. Geriatric
12.6. North America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
12.6.1.1.1.
Recurring
Mouth sores/ genital sores
12.6.1.1.2.
Skin and
joint pain
12.6.1.1.3.
Inflammation
in the eyes
12.6.1.1.4.
Vein
Inflammation
12.6.1.1.5.
Bowel
Problems
12.6.1.1.6.
Others
12.6.1.2.
U.S Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.1.2.1.
Blood
Test
12.6.1.2.2.
Pathergy
test
12.6.1.3.
U.S Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
12.6.1.3.1.
Skin
creams, gels and ointments
12.6.1.3.2.
Eyedrops
12.6.1.3.3.
Corticosteroids
12.6.1.3.4.
Immunosuppressant
drugs
12.6.1.3.5.
Others
12.6.1.4.
U.S Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
12.6.1.4.1.
Children
12.6.1.4.2.
Adults
12.6.1.4.3.
Geriatric
12.6.2. Canada
12.6.2.1.
Canada Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
12.6.2.1.1.
Recurring
Mouth sores/ genital sores
12.6.2.1.2.
Skin and
joint pain
12.6.2.1.3.
Inflammation
in the eyes
12.6.2.1.4.
Vein
Inflammation
12.6.2.1.5.
Bowel
Problems
12.6.2.1.6.
Others
12.6.2.2.
Canada Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.2.2.1.
Blood
Test
12.6.2.2.2.
Pathergy
test
12.6.2.3.
Canada Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
12.6.2.3.1.
Skin
creams, gels and ointments
12.6.2.3.2.
Eyedrops
12.6.2.3.3.
Corticosteroids
12.6.2.3.4.
Immunosuppressant
drugs
12.6.2.3.5.
Others
12.6.2.4.
Canada Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
12.6.2.4.1.
Children
12.6.2.4.2.
Adults
12.6.2.4.3.
Geriatric
12.6.3. Mexico
12.6.3.1.
Mexico Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
12.6.3.1.1.
Recurring
Mouth sores/ genital sores
12.6.3.1.2.
Skin and
joint pain
12.6.3.1.3.
Inflammation
in the eyes
12.6.3.1.4.
Vein
Inflammation
12.6.3.1.5.
Bowel
Problems
12.6.3.1.6.
Others
12.6.3.2.
Mexico Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
12.6.3.2.1.
Blood
Test
12.6.3.2.2.
Pathergy
test
12.6.3.3.
Mexico Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
12.6.3.3.1.
Skin
creams, gels and ointments
12.6.3.3.2.
Eyedrops
12.6.3.3.3.
Corticosteroids
12.6.3.3.4.
Immunosuppressant
drugs
12.6.3.3.5.
Others
12.6.3.4.
Mexico Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
12.6.3.4.1.
Children
12.6.3.4.2.
Adults
12.6.3.4.3.
Geriatric
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Symptoms
12.6.4.1.1.
Recurring
Mouth sores/ genital sores
12.6.4.1.2.
Skin and
joint pain
12.6.4.1.3.
Inflammation
in the eyes
12.6.4.1.4.
Vein
Inflammation
12.6.4.1.5.
Bowel
Problems
12.6.4.1.6.
Others
12.6.4.2.
Rest of
North America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
12.6.4.2.1.
Blood
Test
12.6.4.2.2.
Pathergy
test
12.6.4.3.
Rest of
North America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Treatment
12.6.4.3.1.
Skin
creams, gels and ointments
12.6.4.3.2.
Eyedrops
12.6.4.3.3.
Corticosteroids
12.6.4.3.4.
Immunosuppressant
drugs
12.6.4.3.5.
Others
12.6.4.4.
Rest of
North America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age
Group
12.6.4.4.1.
Children
12.6.4.4.2.
Adults
12.6.4.4.3.
Geriatric
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Symptoms
12.7.3. By Diagnosis
12.7.4. By Treatment
12.7.5. By Age Group
13. Europe Behcet’s Disease Market Analysis and
Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Europe Behcet’s Disease Market Revenue (US$
Mn)
13.2. Europe Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Symptoms
13.2.1. Recurring Mouth sores/ genital sores
13.2.2. Skin and joint pain
13.2.3. Inflammation in the eyes
13.2.4. Vein Inflammation
13.2.5. Bowel Problems
13.2.6. Others
13.3. Europe Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Diagnosis
13.3.1. Blood Test
13.3.2. Pathergy test
13.4. Europe Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Treatment
13.4.1. Skin creams, gels and ointments
13.4.2. Eyedrops
13.4.3. Corticosteroids
13.4.4. Immunosuppressant drugs
13.4.5. Others
13.5. Europe Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Age Group
13.5.1. Children
13.5.2. Adults
13.5.3. Geriatric
13.6. Europe Behcet’s Disease Market Revenue (US$
Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1.
France Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.1.1.1.
Recurring
Mouth sores/ genital sores
13.6.1.1.2.
Skin and
joint pain
13.6.1.1.3.
Inflammation
in the eyes
13.6.1.1.4.
Vein
Inflammation
13.6.1.1.5.
Bowel
Problems
13.6.1.1.6.
Others
13.6.1.2.
France Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.1.2.1.
Blood
Test
13.6.1.2.2.
Pathergy
test
13.6.1.3.
France Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.1.3.1.
Skin
creams, gels and ointments
13.6.1.3.2.
Eyedrops
13.6.1.3.3.
Corticosteroids
13.6.1.3.4.
Immunosuppressant
drugs
13.6.1.3.5.
Others
13.6.1.4.
France Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.1.4.1.
Children
13.6.1.4.2.
Adults
13.6.1.4.3.
Geriatric
13.6.2. The UK
13.6.2.1.
The UK Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.2.1.1.
Recurring
Mouth sores/ genital sores
13.6.2.1.2.
Skin and
joint pain
13.6.2.1.3.
Inflammation
in the eyes
13.6.2.1.4.
Vein
Inflammation
13.6.2.1.5.
Bowel
Problems
13.6.2.1.6.
Others
13.6.2.2.
The UK Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.2.2.1.
Blood
Test
13.6.2.2.2.
Pathergy
test
13.6.2.3.
The UK Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.2.3.1.
Skin
creams, gels and ointments
13.6.2.3.2.
Eyedrops
13.6.2.3.3.
Corticosteroids
13.6.2.3.4.
Immunosuppressant
drugs
13.6.2.3.5.
Others
13.6.2.4.
The UK Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.2.4.1.
Children
13.6.2.4.2.
Adults
13.6.2.4.3.
Geriatric
13.6.3. Spain
13.6.3.1.
Spain Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.3.1.1.
Recurring
Mouth sores/ genital sores
13.6.3.1.2.
Skin and
joint pain
13.6.3.1.3.
Inflammation
in the eyes
13.6.3.1.4.
Vein
Inflammation
13.6.3.1.5.
Bowel
Problems
13.6.3.1.6.
Others
13.6.3.2.
Spain Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.3.2.1.
Blood
Test
13.6.3.2.2.
Pathergy
test
13.6.3.3.
Spain Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.3.3.1.
Skin creams,
gels and ointments
13.6.3.3.2.
Eyedrops
13.6.3.3.3.
Corticosteroids
13.6.3.3.4.
Immunosuppressant
drugs
13.6.3.3.5.
Others
13.6.3.4.
Spain Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.3.4.1.
Children
13.6.3.4.2.
Adults
13.6.3.4.3.
Geriatric
13.6.4. Germany
13.6.4.1.
Germany Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.4.1.1.
Recurring
Mouth sores/ genital sores
13.6.4.1.2.
Skin and
joint pain
13.6.4.1.3.
Inflammation
in the eyes
13.6.4.1.4.
Vein
Inflammation
13.6.4.1.5.
Bowel
Problems
13.6.4.1.6.
Others
13.6.4.2.
Germany Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.4.2.1.
Blood
Test
13.6.4.2.2.
Pathergy
test
13.6.4.3.
Germany Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.4.3.1.
Skin
creams, gels and ointments
13.6.4.3.2.
Eyedrops
13.6.4.3.3.
Corticosteroids
13.6.4.3.4.
Immunosuppressant
drugs
13.6.4.3.5.
Others
13.6.4.4.
Germany Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.4.4.1.
Children
13.6.4.4.2.
Adults
13.6.4.4.3.
Geriatric
13.6.5. Italy
13.6.5.1.
Italy Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.5.1.1.
Recurring
Mouth sores/ genital sores
13.6.5.1.2.
Skin and
joint pain
13.6.5.1.3.
Inflammation
in the eyes
13.6.5.1.4.
Vein
Inflammation
13.6.5.1.5.
Bowel
Problems
13.6.5.1.6.
Others
13.6.5.2.
Italy Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.5.2.1.
Blood
Test
13.6.5.2.2.
Pathergy
test
13.6.5.3.
Italy Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.5.3.1.
Skin
creams, gels and ointments
13.6.5.3.2.
Eyedrops
13.6.5.3.3.
Corticosteroids
13.6.5.3.4.
Immunosuppressant
drugs
13.6.5.3.5.
Others
13.6.5.4.
Italy Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.5.4.1.
Children
13.6.5.4.2.
Adults
13.6.5.4.3.
Geriatric
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.6.1.1.
Recurring
Mouth sores/ genital sores
13.6.6.1.2.
Skin and
joint pain
13.6.6.1.3.
Inflammation
in the eyes
13.6.6.1.4.
Vein
Inflammation
13.6.6.1.5.
Bowel
Problems
13.6.6.1.6.
Others
13.6.6.2.
Nordic
Countries Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.6.2.1.
Blood
Test
13.6.6.2.2.
Pathergy
test
13.6.6.3.
Nordic
Countries Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.6.3.1.
Skin
creams, gels and ointments
13.6.6.3.2.
Eyedrops
13.6.6.3.3.
Corticosteroids
13.6.6.3.4.
Immunosuppressant
drugs
13.6.6.3.5.
Others
13.6.6.4.
Nordic
Countries Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.6.4.1.
Children
13.6.6.4.2.
Adults
13.6.6.4.3.
Geriatric
13.6.6.5.
Nordic
Countries Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.7.1.1.
Recurring
Mouth sores/ genital sores
13.6.7.1.2.
Skin and
joint pain
13.6.7.1.3.
Inflammation
in the eyes
13.6.7.1.4.
Vein
Inflammation
13.6.7.1.5.
Bowel
Problems
13.6.7.1.6.
Others
13.6.7.2.
Benelux
Union Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.7.2.1.
Blood
Test
13.6.7.2.2.
Pathergy
test
13.6.7.3.
Benelux
Union Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.7.3.1.
Skin
creams, gels and ointments
13.6.7.3.2.
Eyedrops
13.6.7.3.3.
Corticosteroids
13.6.7.3.4.
Immunosuppressant
drugs
13.6.7.3.5.
Others
13.6.7.4.
Benelux
Union Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.7.4.1.
Children
13.6.7.4.2.
Adults
13.6.7.4.3.
Geriatric
13.6.7.5.
Benelux
Union Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
13.6.8.1.1.
Recurring
Mouth sores/ genital sores
13.6.8.1.2.
Skin and
joint pain
13.6.8.1.3.
Inflammation
in the eyes
13.6.8.1.4.
Vein
Inflammation
13.6.8.1.5.
Bowel
Problems
13.6.8.1.6.
Others
13.6.8.2.
Rest of
Europe Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
13.6.8.2.1.
Blood
Test
13.6.8.2.2.
Pathergy
test
13.6.8.3.
Rest of
Europe Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
13.6.8.3.1.
Skin
creams, gels and ointments
13.6.8.3.2.
Eyedrops
13.6.8.3.3.
Corticosteroids
13.6.8.3.4.
Immunosuppressant
drugs
13.6.8.3.5.
Others
13.6.8.4.
Rest of
Europe Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
13.6.8.4.1.
Children
13.6.8.4.2.
Adults
13.6.8.4.3.
Geriatric
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Symptoms
13.7.3. By Diagnosis
13.7.4. By Treatment
13.7.5. By Age Group
14. Asia Pacific Behcet’s Disease Market
Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn)
14.2. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Symptoms
14.2.1. Recurring Mouth sores/ genital sores
14.2.2. Skin and joint pain
14.2.3. Inflammation in the eyes
14.2.4. Vein Inflammation
14.2.5. Bowel Problems
14.2.6. Others
14.3. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
14.3.1. Blood Test
14.3.2. Pathergy test
14.4. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Treatment
14.4.1. Skin creams, gels and ointments
14.4.2. Eyedrops
14.4.3. Corticosteroids
14.4.4. Immunosuppressant drugs
14.4.5. Others
14.5. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Age Group
14.5.1. Children
14.5.2. Adults
14.5.3. Geriatric
14.6. Asia Pacific Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.1.1.1.
Recurring
Mouth sores/ genital sores
14.6.1.1.2.
Skin and
joint pain
14.6.1.1.3.
Inflammation
in the eyes
14.6.1.1.4.
Vein
Inflammation
14.6.1.1.5.
Bowel
Problems
14.6.1.1.6.
Others
14.6.1.2.
China Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.1.2.1.
Blood
Test
14.6.1.2.2.
Pathergy
test
14.6.1.3.
China Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.1.3.1.
Skin
creams, gels and ointments
14.6.1.3.2.
Eyedrops
14.6.1.3.3.
Corticosteroids
14.6.1.3.4.
Immunosuppressant
drugs
14.6.1.3.5.
Others
14.6.1.4.
China Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.1.4.1.
Children
14.6.1.4.2.
Adults
14.6.1.4.3.
Geriatric
14.6.2. Japan
14.6.2.1.
Japan Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.2.1.1.
Recurring
Mouth sores/ genital sores
14.6.2.1.2.
Skin and
joint pain
14.6.2.1.3.
Inflammation
in the eyes
14.6.2.1.4.
Vein
Inflammation
14.6.2.1.5.
Bowel
Problems
14.6.2.1.6.
Others
14.6.2.2.
Japan Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.2.2.1.
Blood
Test
14.6.2.2.2.
Pathergy
test
14.6.2.3.
Japan Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.2.3.1.
Skin
creams, gels and ointments
14.6.2.3.2.
Eyedrops
14.6.2.3.3.
Corticosteroids
14.6.2.3.4.
Immunosuppressant
drugs
14.6.2.3.5.
Others
14.6.2.4.
Japan Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.2.4.1.
Children
14.6.2.4.2.
Adults
14.6.2.4.3.
Geriatric
14.6.3. India
14.6.3.1.
India Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.3.1.1.
Recurring
Mouth sores/ genital sores
14.6.3.1.2.
Skin and
joint pain
14.6.3.1.3.
Inflammation
in the eyes
14.6.3.1.4.
Vein
Inflammation
14.6.3.1.5.
Bowel
Problems
14.6.3.1.6.
Others
14.6.3.2.
India Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.3.2.1.
Blood
Test
14.6.3.2.2.
Pathergy
test
14.6.3.3.
India Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.3.3.1.
Skin
creams, gels and ointments
14.6.3.3.2.
Eyedrops
14.6.3.3.3.
Corticosteroids
14.6.3.3.4.
Immunosuppressant
drugs
14.6.3.3.5.
Others
14.6.3.4.
India Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.3.4.1.
Children
14.6.3.4.2.
Adults
14.6.3.4.3.
Geriatric
14.6.4. New Zealand
14.6.4.1.
New
Zealand Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.4.1.1.
Recurring
Mouth sores/ genital sores
14.6.4.1.2.
Skin and
joint pain
14.6.4.1.3.
Inflammation
in the eyes
14.6.4.1.4.
Vein
Inflammation
14.6.4.1.5.
Bowel
Problems
14.6.4.1.6.
Others
14.6.4.2.
New
Zealand Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.4.2.1.
Blood
Test
14.6.4.2.2.
Pathergy
test
14.6.4.3.
New
Zealand Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.4.3.1.
Skin
creams, gels and ointments
14.6.4.3.2.
Eyedrops
14.6.4.3.3.
Corticosteroids
14.6.4.3.4.
Immunosuppressant
drugs
14.6.4.3.5.
Others
14.6.4.4.
New
Zealand Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.4.4.1.
Children
14.6.4.4.2.
Adults
14.6.4.4.3.
Geriatric
14.6.5. Australia
14.6.5.1.
Australia
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.5.1.1.
Recurring
Mouth sores/ genital sores
14.6.5.1.2.
Skin and
joint pain
14.6.5.1.3.
Inflammation
in the eyes
14.6.5.1.4.
Vein
Inflammation
14.6.5.1.5.
Bowel
Problems
14.6.5.1.6.
Others
14.6.5.2.
Australia
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.5.2.1.
Blood
Test
14.6.5.2.2.
Pathergy
test
14.6.5.3.
Australia
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.5.3.1.
Skin
creams, gels and ointments
14.6.5.3.2.
Eyedrops
14.6.5.3.3.
Corticosteroids
14.6.5.3.4.
Immunosuppressant
drugs
14.6.5.3.5.
Others
14.6.5.4.
Australia
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.5.4.1.
Children
14.6.5.4.2.
Adults
14.6.5.4.3.
Geriatric
14.6.6. South Korea
14.6.6.1.
South
Korea Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.6.1.1.
Recurring
Mouth sores/ genital sores
14.6.6.1.2.
Skin and
joint pain
14.6.6.1.3.
Inflammation
in the eyes
14.6.6.1.4.
Vein
Inflammation
14.6.6.1.5.
Bowel
Problems
14.6.6.1.6.
Others
14.6.6.2.
South
Korea Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.6.2.1.
Blood
Test
14.6.6.2.2.
Pathergy
test
14.6.6.3.
South
Korea Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.6.3.1.
Skin
creams, gels and ointments
14.6.6.3.2.
Eyedrops
14.6.6.3.3.
Corticosteroids
14.6.6.3.4.
Immunosuppressant
drugs
14.6.6.3.5.
Others
14.6.6.4.
South
Korea Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.6.4.1.
Children
14.6.6.4.2.
Adults
14.6.6.4.3.
Geriatric
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
14.6.7.1.1.
Recurring
Mouth sores/ genital sores
14.6.7.1.2.
Skin and
joint pain
14.6.7.1.3.
Inflammation
in the eyes
14.6.7.1.4.
Vein
Inflammation
14.6.7.1.5.
Bowel
Problems
14.6.7.1.6.
Others
14.6.7.2.
Southeast
Asia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
14.6.7.2.1.
Blood
Test
14.6.7.2.2.
Pathergy
test
14.6.7.3.
Southeast
Asia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
14.6.7.3.1.
Skin
creams, gels and ointments
14.6.7.3.2.
Eyedrops
14.6.7.3.3.
Corticosteroids
14.6.7.3.4.
Immunosuppressant
drugs
14.6.7.3.5.
Others
14.6.7.4.
Southeast
Asia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
14.6.7.4.1.
Children
14.6.7.4.2.
Adults
14.6.7.4.3.
Geriatric
14.6.7.5.
Southeast
Asia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Symptoms
14.6.8.1.1.
Recurring
Mouth sores/ genital sores
14.6.8.1.2.
Skin and
joint pain
14.6.8.1.3.
Inflammation
in the eyes
14.6.8.1.4.
Vein
Inflammation
14.6.8.1.5.
Bowel
Problems
14.6.8.1.6.
Others
14.6.8.2.
Rest of
Asia Pacific Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
14.6.8.2.1.
Blood
Test
14.6.8.2.2.
Pathergy
test
14.6.8.3.
Rest of
Asia Pacific Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Treatment
14.6.8.3.1.
Skin
creams, gels and ointments
14.6.8.3.2.
Eyedrops
14.6.8.3.3.
Corticosteroids
14.6.8.3.4.
Immunosuppressant
drugs
14.6.8.3.5.
Others
14.6.8.4.
Rest of
Asia Pacific Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.6.8.4.1.
Children
14.6.8.4.2.
Adults
14.6.8.4.3.
Geriatric
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Symptoms
14.7.3. By Diagnosis
14.7.4. By Treatment
14.7.5. By Age Group
15. Middle East and Africa Behcet’s Disease
Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn)
15.2. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.2.1. Recurring Mouth sores/ genital sores
15.2.2. Skin and joint pain
15.2.3. Inflammation in the eyes
15.2.4. Vein Inflammation
15.2.5. Bowel Problems
15.2.6. Others
15.3. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.3.1. Blood Test
15.3.2. Pathergy test
15.4. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn) and Forecasts, By Treatment
15.4.1. Skin creams, gels and ointments
15.4.2. Eyedrops
15.4.3. Corticosteroids
15.4.4. Immunosuppressant drugs
15.4.5. Others
15.5. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn) and Forecasts, By Age Group
15.5.1. Children
15.5.2. Adults
15.5.3. Geriatric
15.6. Middle East and Africa Behcet’s Disease
Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.6.1.1.1.
Recurring
Mouth sores/ genital sores
15.6.1.1.2.
Skin and
joint pain
15.6.1.1.3.
Inflammation
in the eyes
15.6.1.1.4.
Vein
Inflammation
15.6.1.1.5.
Bowel
Problems
15.6.1.1.6.
Others
15.6.1.2.
Saudi
Arabia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.1.2.1.
Blood
Test
15.6.1.2.2.
Pathergy
test
15.6.1.3.
Saudi
Arabia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.1.3.1.
Skin
creams, gels and ointments
15.6.1.3.2.
Eyedrops
15.6.1.3.3.
Corticosteroids
15.6.1.3.4.
Immunosuppressant
drugs
15.6.1.3.5.
Others
15.6.1.4.
Saudi
Arabia Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.1.4.1.
Children
15.6.1.4.2.
Adults
15.6.1.4.3.
Geriatric
15.6.2. UAE
15.6.2.1.
UAE Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.6.2.1.1.
Recurring
Mouth sores/ genital sores
15.6.2.1.2.
Skin and
joint pain
15.6.2.1.3.
Inflammation
in the eyes
15.6.2.1.4.
Vein
Inflammation
15.6.2.1.5.
Bowel
Problems
15.6.2.1.6.
Others
15.6.2.2.
UAE Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.2.2.1.
Blood
Test
15.6.2.2.2.
Pathergy
test
15.6.2.3.
UAE Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.2.3.1.
Skin
creams, gels and ointments
15.6.2.3.2.
Eyedrops
15.6.2.3.3.
Corticosteroids
15.6.2.3.4.
Immunosuppressant
drugs
15.6.2.3.5.
Others
15.6.2.4.
UAE Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.2.4.1.
Children
15.6.2.4.2.
Adults
15.6.2.4.3.
Geriatric
15.6.3. Egypt
15.6.3.1.
Egypt Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.6.3.1.1.
Recurring
Mouth sores/ genital sores
15.6.3.1.2.
Skin and
joint pain
15.6.3.1.3.
Inflammation
in the eyes
15.6.3.1.4.
Vein
Inflammation
15.6.3.1.5.
Bowel
Problems
15.6.3.1.6.
Others
15.6.3.2.
Egypt Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.3.2.1.
Blood
Test
15.6.3.2.2.
Pathergy
test
15.6.3.3.
Egypt Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.3.3.1.
Skin
creams, gels and ointments
15.6.3.3.2.
Eyedrops
15.6.3.3.3.
Corticosteroids
15.6.3.3.4.
Immunosuppressant
drugs
15.6.3.3.5.
Others
15.6.3.4.
Egypt Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.3.4.1.
Children
15.6.3.4.2.
Adults
15.6.3.4.3.
Geriatric
15.6.4. Kuwait
15.6.4.1.
Kuwait Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.6.4.1.1.
Recurring
Mouth sores/ genital sores
15.6.4.1.2.
Skin and
joint pain
15.6.4.1.3.
Inflammation
in the eyes
15.6.4.1.4.
Vein
Inflammation
15.6.4.1.5.
Bowel
Problems
15.6.4.1.6.
Others
15.6.4.2.
Kuwait Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.4.2.1.
Blood
Test
15.6.4.2.2.
Pathergy
test
15.6.4.3.
Kuwait Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.4.3.1.
Skin
creams, gels and ointments
15.6.4.3.2.
Eyedrops
15.6.4.3.3.
Corticosteroids
15.6.4.3.4.
Immunosuppressant
drugs
15.6.4.3.5.
Others
15.6.4.4.
Kuwait Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.4.4.1.
Children
15.6.4.4.2.
Adults
15.6.4.4.3.
Geriatric
15.6.5. South Africa
15.6.5.1.
South
Africa Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
15.6.5.1.1.
Recurring
Mouth sores/ genital sores
15.6.5.1.2.
Skin and
joint pain
15.6.5.1.3.
Inflammation
in the eyes
15.6.5.1.4.
Vein
Inflammation
15.6.5.1.5.
Bowel
Problems
15.6.5.1.6.
Others
15.6.5.2.
South
Africa Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
15.6.5.2.1.
Blood
Test
15.6.5.2.2.
Pathergy
test
15.6.5.3.
South
Africa Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.5.3.1.
Skin
creams, gels and ointments
15.6.5.3.2.
Eyedrops
15.6.5.3.3.
Corticosteroids
15.6.5.3.4.
Immunosuppressant
drugs
15.6.5.3.5.
Others
15.6.5.4.
South
Africa Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.5.4.1.
Children
15.6.5.4.2.
Adults
15.6.5.4.3.
Geriatric
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Behcet’s Disease Market Revenue (US$ Mn) and
Forecasts, By Symptoms
15.6.6.1.1.
Recurring
Mouth sores/ genital sores
15.6.6.1.2.
Skin and
joint pain
15.6.6.1.3.
Inflammation
in the eyes
15.6.6.1.4.
Vein
Inflammation
15.6.6.1.5.
Bowel
Problems
15.6.6.1.6.
Others
15.6.6.2.
Rest of
Middle East & Africa Behcet’s Disease Market Revenue (US$ Mn) and
Forecasts, By Diagnosis
15.6.6.2.1.
Blood
Test
15.6.6.2.2.
Pathergy
test
15.6.6.3.
Rest of
Middle East & Africa Behcet’s Disease Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.6.3.1.
Skin
creams, gels and ointments
15.6.6.3.2.
Eyedrops
15.6.6.3.3.
Corticosteroids
15.6.6.3.4.
Immunosuppressant
drugs
15.6.6.3.5.
Others
15.6.6.4.
Rest of
Middle East & Africa Behcet’s Disease Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.6.6.4.1.
Children
15.6.6.4.2.
Adults
15.6.6.4.3.
Geriatric
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Symptoms
15.7.3. By Diagnosis
15.7.4. By Treatment
15.7.5. By Age Group
16. Latin America Behcet’s Disease Market
Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Latin America Behcet’s Disease Market Revenue
(US$ Mn)
16.2. Latin America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Symptoms
16.2.1. Recurring Mouth sores/ genital sores
16.2.2. Skin and joint pain
16.2.3. Inflammation in the eyes
16.2.4. Vein Inflammation
16.2.5. Bowel Problems
16.2.6. Others
16.3. Latin America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Diagnosis
16.3.1. Blood Test
16.3.2. Pathergy test
16.4. Latin America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Treatment
16.4.1. Skin creams, gels and ointments
16.4.2. Eyedrops
16.4.3. Corticosteroids
16.4.4. Immunosuppressant drugs
16.4.5. Others
16.5. Latin America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Age Group
16.5.1. Children
16.5.2. Adults
16.5.3. Geriatric
16.6. Latin America Behcet’s Disease Market Revenue
(US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
16.6.1.1.1.
Recurring
Mouth sores/ genital sores
16.6.1.1.2.
Skin and
joint pain
16.6.1.1.3.
Inflammation
in the eyes
16.6.1.1.4.
Vein
Inflammation
16.6.1.1.5.
Bowel
Problems
16.6.1.1.6.
Others
16.6.1.2.
Brazil Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.6.1.2.1.
Blood
Test
16.6.1.2.2.
Pathergy
test
16.6.1.3.
Brazil Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
16.6.1.3.1.
Skin
creams, gels and ointments
16.6.1.3.2.
Eyedrops
16.6.1.3.3.
Corticosteroids
16.6.1.3.4.
Immunosuppressant
drugs
16.6.1.3.5.
Others
16.6.1.4.
Brazil Behcet’s
Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
16.6.1.4.1.
Children
16.6.1.4.2.
Adults
16.6.1.4.3.
Geriatric
16.6.2. Argentina
16.6.2.1.
Argentina
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Symptoms
16.6.2.1.1.
Recurring
Mouth sores/ genital sores
16.6.2.1.2.
Skin and
joint pain
16.6.2.1.3.
Inflammation
in the eyes
16.6.2.1.4.
Vein
Inflammation
16.6.2.1.5.
Bowel
Problems
16.6.2.1.6.
Others
16.6.2.2.
Argentina
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Diagnosis
16.6.2.2.1.
Blood
Test
16.6.2.2.2.
Pathergy
test
16.6.2.3.
Argentina
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Treatment
16.6.2.3.1.
Skin
creams, gels and ointments
16.6.2.3.2.
Eyedrops
16.6.2.3.3.
Corticosteroids
16.6.2.3.4.
Immunosuppressant
drugs
16.6.2.3.5.
Others
16.6.2.4.
Argentina
Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age Group
16.6.2.4.1.
Children
16.6.2.4.2.
Adults
16.6.2.4.3.
Geriatric
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Symptoms
16.6.3.1.1.
Recurring
Mouth sores/ genital sores
16.6.3.1.2.
Skin and
joint pain
16.6.3.1.3.
Inflammation
in the eyes
16.6.3.1.4.
Vein
Inflammation
16.6.3.1.5.
Bowel
Problems
16.6.3.1.6.
Others
16.6.3.2.
Rest of
Latin America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Diagnosis
16.6.3.2.1.
Blood
Test
16.6.3.2.2.
Pathergy
test
16.6.3.3.
Rest of
Latin America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By
Treatment
16.6.3.3.1.
Skin
creams, gels and ointments
16.6.3.3.2.
Eyedrops
16.6.3.3.3.
Corticosteroids
16.6.3.3.4.
Immunosuppressant
drugs
16.6.3.3.5.
Others
16.6.3.4.
Rest of
Latin America Behcet’s Disease Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.6.3.4.1.
Children
16.6.3.4.2.
Adults
16.6.3.4.3.
Geriatric
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Symptoms
16.7.3. By Diagnosis
16.7.4. By Treatment
16.7.5. By Age Group
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Amgen Inc
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Aristea Therapeutics.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. CELGENE CORPORATION (A BRISTOL-MYERS SQUIBB
COMPANY)
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Eisai Co., Ltd.
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. KANGPU
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. XOMA Corporation.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7.
Business
Strategies
18.7. Other Market Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
